RA Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.4M | Buy |
23,555,648
+12,683,145
| +117% | +$29.3M | 0.92% | 25 |
|
|
2025
Q1 | $15.1M | Hold |
10,872,503
| – | – | 0.25% | 55 |
|
|
2024
Q4 | $18.8M | Hold |
10,872,503
| – | – | 0.25% | 58 |
|
|
2024
Q3 | $21.9M | Hold |
10,872,503
| – | – | 0.25% | 53 |
|
|
2024
Q2 | $24.4M | Hold |
10,872,503
| – | – | 0.32% | 48 |
|
|
2024
Q1 | $31.2M | Sell |
10,872,503
-7,600,000
| -41% | -$21.8M | 0.4% | 50 |
|
|
2023
Q4 | $32.7M | Hold |
18,472,503
| – | – | 0.51% | 38 |
|
|
2023
Q3 | $58.4M | Buy |
+18,472,503
| New | +$58.4M | 1.15% | 25 |
|